| C |
| C Wermes |
- |
Reproductive Choices, Pregnancies and Deliveries in Carriers of Hemophilia Results of the CarrierQOL-Study |
| C La Greca |
- |
Proposal of Immunotolerance Induction in Haemophiliacs A with Inhibitors Undergoing to Pressing Elective Surgery by Using FVIII/vWF-enriched Pure Plasmaderivates |
| C Cavalheiro-Filho |
- |
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital |
| Cabiddu M |
- |
The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma |
| Cabral KMS |
- |
Phospholipids (PL) Induce a Conformational Change Required for Protein Z-Dependent Protease Inhibitor (ZPI) Inhibition of Factor Xa But Not Factor IXa |
| Cabrera N |
- |
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations |
| Cabrera N |
- |
von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre |
| |
- |
Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit |
| |
- |
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects |
| Cabric S |
- |
Heparinization of the Pancreatic Islet Surface as a Mean to Reduce Harmful Blood Clotting after Intraportal Islet Transplantation |
| Cachier A |
- |
Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study |
| Caciolli S |
- |
Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery |
| Cadavid AP |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| Cadavid AP |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| Caesar C |
- |
Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease |
| Çaglayan H |
- |
von Willebrand Disease Type 2N (Normandy) in Three Siblings |
| Cai H |
- |
Serum Amyloid A (SAA) Induces Monocyte Tissue Factor |
| Cai X-y |
- |
Alteration of Protein Z in Malignant Tumors and Its Significance |
| Cai XH |
- |
Two Heterozygous Mutations of F8 Gene in a Female with Hemophilia A |
| Caille D |
- |
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion |
| Caine GJ |
- |
Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer |
| Calabrese F |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Calabrò G |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Calaminus SDJ |
- |
Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen |
| |
- |
Rho Kinase Regulates Platelet Adhesion and Aggregation on Collagen under Flow |
| Calatzis A |
- |
The Role of Platelet Factor 4 and the Use of Dextran Sulfate in Anti Factor Xa Assays: Overestimation of Anticoagulant Activity in LMWH Therapy? |
| Calatzis A |
- |
Assessment of Cyclooxygenase, ADP Receptor and GpIIb/IIIa Receptor Blockade by Impedance Aggregometry Using the Multiplate Analyzer |
| Callas PW |
- |
Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors |
| |
- |
Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels |
| Calmel-Tareau C |
- |
Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas |
| Calmuntia M |
- |
Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous |
| Calo D |
- |
Redox-Regulated Coupling of ADP Receptor Signaling and Integrin Function in Platelets |
| Calori G |
- |
Association of High Lipoprotein(a) and Fibrinogen Levels Predicts Coronary Heart Disease and Cerebro-vascular Mortality in an Elderly (>=65 years) Northern Italian Population |
| Calvo R |
- |
Population Pharmacokinetics of the ReFacto® Factor VIII for Prophylactic Treatment of HIV- and HIV+ Individuals with Haemophilia A |
| Calzolari F |
- |
Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer |
| Camargo E |
- |
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis |
| Cambien F |
- |
Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions |
| Cambus F |
- |
A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations |
| Cambus JP |
- |
A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations |
| |
- |
We Still Need to Organize French Anticoagulation Clinics |
| Camera M |
- |
Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome |
| |
- |
Regulation of Tissue Factor Expression in Human Platelet by Nitric Oxide |
| Cameron LD |
- |
Attitudes about Genetic Testing for Thrombophilia in a Large Family with Heritable Protein C Deficiency |
| Cameron C |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| Camilleri RS |
- |
ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients |
| Camilloni B |
- |
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial |
| Camino-López S |
- |
Statins Prevent the Increase of Tissue Factor Activity and Microparticle Release Induced by Aggregated LDL in Human Vascular Smooth Muscle Cells |
| Camire RM |
- |
Factor V Leiden as a Modifier of the Severe Hemophilia Phenotype in Murine Models |
| |
- |
Hemostatic Effects of Long-Term Expression of Activated Murine FVII in Normal and Hemophilic Mice |
| Camire RM |
- |
Removal of Hirudin-Like Sequences within the Factor Va Heavy Chain Does Not Impair Prothrombinase Function |
| |
- |
Characterization of B-Domain Sequences on Factor V Which Influence the Procofactor to Cofactor Transition |
| Camoin-Jau L |
- |
Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients |
| Camp P |
- |
Gene Expression Abnormalities in Aspirin Hyper-responders |
| Campart D |
- |
The Stable Prostacyclin Analog Iloprost Induces The Production of the Angiogenic Factor Oncostatin M by Monocytes in a p38K-dependent Pathway |
| Campbell DM |
- |
ABO and Secretor Genotypes and the Risk of Pre-Eclampsia |
| Campbell J |
- |
Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency |
| Campbell D |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Campbell K |
- |
GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains |
| Campbell J |
- |
Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients |
| |
- |
Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy |
| Campbell K |
- |
There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation |
| Camporese G |
- |
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study |
| Camporese G |
- |
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study) |
| Camporese G |
- |
Utility Of D-Dimer in the Diagnosis of Deep Venous Thrombosis in Hospitalized Patients at High Risk of Venous Thromboembolism |
| Campos M |
- |
The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients |
| Campos L |
- |
Confirmation of the Pathogenic Role of Ig M and Ig A Anti Heparin-PF4 Antibodies in Patients with Heparin-Induced-Thrombocytopenia |
| Camps S |
- |
Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach |
| Canault M |
- |
The TNF Alpha Converting Enzyme (TACE/ADAM17) Is Expressed in the Atherosclerotic Lesion of ApoE-deficient Mice |
| Canciani M |
- |
Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study |
| Canciani MT |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Candolfi R |
- |
A New Automatic Method to Measure Adamts 13 |
| Canella A |
- |
Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency |
| |
- |
CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction |
| Cannegieter SC |
- |
Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study |
| |
- |
Coagulation in Aviation: Activation of the Coagulation System During Air Travel (The WRIGHT Volunteers Study) |
| |
- |
The Absolute Risk of Venous Thrombosis after Air Travel (WRIGHT Study) |
| |
- |
Incidence of Venous Thromboembolism Among Dutch Airline Pilots |
| Cannizzaro V |
- |
Complete Thrombolysis of Bilateral Pulmonary Embolism by Two-Sided Catheter-Directed Low-Dose Infusion of Tissue Plasminogen Activator |
| |
- |
Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis |
| Cannon M |
- |
Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis |
| Cannon S |
- |
Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis |
| Cano H |
- |
Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone |
| |
- |
Conformational and Functional Changes in Antithrombin by Oxidation |
| Cano H |
- |
Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus |
| Cano H |
- |
Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic? |
| Canobbio I |
- |
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with  -Related Disease |
| |
- |
Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets |
| Canova C |
- |
Swiss Atherothrombosis Survey A Field report on the Occurrence of Symptomatic and Asymptomatic Peripheral Arterial Disease |
| Cantillon CE |
- |
The 80+ Hemorrhagic Cohort Study Rates, Severity and Predictors of Major Hemorrhage in a Cohort of Anticoagulated Atrial Fibrillation Patients |
| Canu P |
- |
Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit |
| Cao JY |
- |
Haemostatic Characters during Liver Transplantation with Preoperative DIC |
| Caponi C |
- |
High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients |
| |
- |
A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry MASTER): Description of the study cohort |
| Cappelli R |
- |
Prognostic Role of Inflammatory Markers in Elderly Patients with Acute Ischemic Stroke |
| |
- |
Epidemiology of Pulmonary Embolism in Elderly Patients Admitted in an Italian Teaching Hospital: Preliminary Data of a Ten years Retrospective Analysis |
| |
- |
Acute Phase of Inflammation and Mortality in Elderly Patients with Pulmonary Embolism |
| Cappucci F |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| |
- |
The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia |
| Cappuccio FP |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| Cappuccio F |
- |
Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study |
| Capraru M |
- |
VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells |
| Caprini J |
- |
Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study |
| |
- |
Barriers to Appropriate Anticoagulation with Warfarin in Orthopedic Surgery |
| Caprini JA |
- |
Fatal Vascular Outcomes Following Major Orthopedic Surgery |
| Caramori ML |
- |
Intraoperative Automatic Autotransfusion for Lung Transplantation |
| Carandina S |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Carballo GA |
- |
Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family |
| Carbillon L |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| Carbone S |
- |
Phospholipid Correction of Prolonged Kaolin Clotting Times. Validating the Diagnosis of a Lupus Anticoagulant |
| Carbone A |
- |
Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin |
| Carbone S |
- |
Are High Factor VIII Levels in Combination with High Fibrinogen Levels a Consistent Finding in Compromised Obstetric Cases Particularly Preeclampsia? |
| Carcao M |
- |
Time In-Situ as a Risk Factor for Central Venous Catheter Associated Thrombosis (CVC-Clot) in Severe Hemophiliacs (SH) |
| Cardona H |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| Cardona-Maya WD |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| Cardona-Maya W |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| Cardoso JE |
- |
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients |
| |
- |
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| Carella A |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| Cariou R |
- |
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials |
| Carlo A |
- |
The Thrombogram in Twins, Influence of Oral Contraceptive and Intercurrent Infection |
| Carlsson A |
- |
Human Aortic Endothelial Cells Inhibit Thrombin Generation in vitro and Augment Inhibition by Melagatran |
| Carluccio MA |
- |
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression |
| |
- |
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release |
| |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| Carluccio M |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| Carmassi F |
- |
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature |
| Carmassi F |
- |
Spontaneously Acquired Factor VIII and IX Inhibitors in a Patient with Sjogren Syndrome |
| Carmeliet P |
- |
Roles of Platelet ADP and Gas6 Receptors in Thrombus Stability |
| |
- |
Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium |
| |
- |
Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications |
| Carneiro JDA |
- |
Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin |
| Carneiro JDA |
- |
Thromboembolic Complications of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: Effects of the Disease and the Therapy on the Hemostatic System |
| Carnero J |
- |
Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit |
| Carol H |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Carollo C |
- |
Cerebral Venous Thrombosis: The Padua Experience |
| Carolyn W |
- |
The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms |
| Caron C |
- |
A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study |
| |
- |
The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study |
| |
- |
Acquired von Willebrand Syndrome Due to an Antibody Against von Willebrand Factor Associated to a Strong Platelet Thromboagglutinin Simulating a Type 2B von Willebrand Disease |
| |
- |
New Mutation Inducing a von Willebrand 2A Disease |
| |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| Carotti A |
- |
Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain |
| Carpani G |
- |
Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions |
| Carpenedo M |
- |
Quality of Life (QoL) in Patients Receiving Vitamin K Antagonists (VKA): A Study Using EQ-5D Questionnaire |
| Carpenedo M |
- |
Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets |
| |
- |
Conjoint Analysis to Elicit Preferences on Anticoagulant Treatment in Patients Receiving Vitamin K Antagonists (VKA) |
| Carpinelli M |
- |
Molecular Dissection of Platelet Production Via Random Mutagenesis |
| Carr P |
- |
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles |
| Carroll WE |
- |
Improved Oral Anticoagulant Therapy Monitoring by Eliminating ISI and MNPT from INR Determinations |
| Carruthers J |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| Carter AM |
- |
A Proteomics Approach for the Identification of Plasma Transglutaminase (FXIII) Substrates |
| |
- |
Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain |
| Carter AM |
- |
Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation |
| Carter AM |
- |
Characterizing the Plasma Clot Proteome |
| Carter AM |
- |
Polymorphic Markers and Arterial Thrombosis: Where Next? |
| |
- |
CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome? |
| Caruso S |
- |
Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway |
| Carvalho MG |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| |
- |
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers |
| |
- |
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients |
| |
- |
Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools? |
| |
- |
Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| Carville D |
- |
Dose-Dependent Clopidogrel-Atorvastatin DrugDrug Interaction Determined by Light Transmission Aggregometry |
| Carville D |
- |
Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients |
| Casaña P |
- |
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects |
| Casais P |
- |
Anti Factor VIII Inhibitor: A Single Institution Experience |
| |
- |
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients |
| |
- |
Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family |
| Casais P |
- |
Oral Anticoagulation in Patients over 80 Years with Atrial Fibrillation |
| Casaña P |
- |
von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre |
| |
- |
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations |
| |
- |
Optimisation of Ristocetin Cofactor Test for Low Activity Samples |
| |
- |
Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit |
| Casanegra AI |
- |
Clinical Audit of Thromboembolism Prophylaxis 3 years after the 6th ACCP Report in a Tertiary Care Hospital in Córdoba, Argentina |
| Casetta B |
- |
Proteomic Analysis of High-Density Lipoprotein |
| Casey G |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Casey CR |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Casini A |
- |
Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes |
| |
- |
Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels |
| |
- |
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects |
| Casonato A |
- |
How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype |
| |
- |
FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease |
| Castaldi D |
- |
TAFI 325/Ile Genotype in Old Population of Northern Italy |
| Castaman G |
- |
Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect |
| |
- |
In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study |
| |
- |
Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD |
| |
- |
Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype |
| |
- |
Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation |
| |
- |
Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study |
| Castaman G |
- |
Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study |
| |
- |
Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study |
| Castaman G |
- |
Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects |
| Castaman G |
- |
Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study |
| Castaman G |
- |
Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD |
| |
- |
Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study |
| |
- |
Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study |
| |
- |
Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study |
| |
- |
In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency |
| Castaman G |
- |
Eight Novel Mutations in FXI Gene |
| Castaman G |
- |
Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A |
| |
- |
A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study |
| |
- |
The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project |
| Castaneda SA |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| Castaneda SA |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| Castel D |
- |
Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice |
| |
- |
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice |
| Castellani D |
- |
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement |
| Castelli R |
- |
The Heparins and Cancer: Review of Clinical Trials and Biological Properties |
| Castelli M |
- |
Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study |
| Castellino F |
- |
Plasminogen Inhibits Monocyte Apoptosis |
| Castellino FJ |
- |
A Novel Role for Maternal Protein C in Embryonic Development |
| Castellone DD |
- |
Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity |
| Castelnuovo AD |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| Casteneda J |
- |
A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression |
| Castillo V |
- |
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss |
| Castillo J |
- |
Antagonism of TxA2 Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function |
| Castle D |
- |
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series |
| |
- |
Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children |
| Castoldi E |
- |
Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients |
| Castrellon A |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Caswell M |
- |
The Application of New Diagnostic Guidelines in Type 1 von Willebrand Disease to Patients Previously Diagnosed Under the UK 1995 Guidelines. A Single Centre Paediatric Experience |
| Catania V |
- |
Clinical Manifestations of Patients with Dysfibrinogenemia |
| Catchpole I |
- |
A Negative Venous Duplex Ultrasound Scan Alone Excludes Deep Venous Thrombosis in Clinical Practice |
| Catozzi L |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Cattaneo M |
- |
Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial |
| |
- |
Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells |
| Cattaneo A |
- |
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis |
| Cattaneo M |
- |
Platelet Aggregation Studies: Autologous Platelet-Poor Plasma Inhibits Platelet Aggregation When Added to Platelet-Rich Plasma to Normalize Platelet Count |
| Cattaneo M |
- |
Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial |
| |
- |
Laboratory Testing, Diagnosis and Management of Platelet Disorders |
| Cattaneo M |
- |
Glucosylceramide Synthase, Glucosylceramide Plasma-Based Assay and Prothrombotic Conditions |
| |
- |
Role of the Platelet P2Y1 Receptor in Thrombus Formation Under Flow Conditions |
| Cattini MG |
- |
How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype |
| |
- |
FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease |
| Caturla J |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| Cauchie P |
- |
New Mutation Inducing a von Willebrand 2A Disease |
| |
- |
Circulating Platelet-Monocyte Complexes Are Inversely Correlated with Serum Apo-A Levels |
| Caulin C |
- |
Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study |
| |
- |
The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study |
| Cauwenberghs S |
- |
Platelet ADP Receptor Function Rapidly Deteriorates in Additive Solutions |
| Cauwenberghs S |
- |
Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation |
| |
- |
Plasma Ecto-NTPDase Prevents Platelet P2X1 and P2Y12 Receptor Desensitization During Storage |
| Cauwenberghs N |
- |
Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody |
| Cavalheiro Filho C |
- |
Intraoperative Automatic Autotransfusion for Lung Transplantation |
| Cavalheiro-Filho C |
- |
Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study |
| |
- |
D-Dimer Assay Used in the Diagnosis of Acute Venous Thromboembolism |
| |
- |
Oral Anticoagulation Laboratory Control: Comparison between Two Differents Methods |
| |
- |
Heparin Induced Thrombocytopenia Type II In Cardiac Hemodialysis Brazilian Patients |
| Cavalheiro-Filho C |
- |
Anticoagulation Therapy in the Osteonecrosis |
| Cazenave J-P |
- |
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times |
| Cazenave JP |
- |
The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Three European Blood Centers |
| |
- |
Two-Phase Antithrombotic Protection after Anti-GPVI Treatment in Mice |
| Cazzaniga M |
- |
The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma |
| |
- |
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests |
| CC1 |
- |
Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study) |
| Ceccarelli E |
- |
Prognostic Role of Inflammatory Markers in Elderly Patients with Acute Ischemic Stroke |
| Ceccarelli C |
- |
Crystal Structure of Calcium- and Integrin-Binding Protein 1: Insights to a Novel Mechanism of Action |
| Cecchi E |
- |
Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy |
| |
- |
High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism |
| |
- |
Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk |
| |
- |
Warfarin Therapy in AF Patients: Females Are Still at Risk |
| |
- |
Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients |
| Cécile K |
- |
Is the Maternal anti HPA-1a Antibody Concentration a Useful Parameter for Antenatal Management of High-risk Pregnancies? |
| Cederholm I |
- |
Whole Blood Clotting Time in the Presence of the Platelet PAR-1 Activating Peptide TRAP-6 Predicts Post-operative Bleeding in Open-heart Surgery A Pilot Study Utilizing Free Oscillation Rheometry |
| Cederholm-Williams S |
- |
The Effect of Fibrin Degradation Products on Neuroendocrine Cells |
| Cedrone A |
- |
Probable Involvement of Endogenous Platelet Protease(s) in PAR-Dependent Platelet Activation |
| Cejna M |
- |
Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model |
| Celentano A |
- |
Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary |
| Celestini A |
- |
Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients |
| Celik I |
- |
Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo |
| Celikel R |
- |
Modulation of Von Willebrand Factor A1 Domain-Mediated Platelet Aggregation by a-Thrombin |
| Celinska-Löwenhoff M |
- |
Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients |
| |
- |
Thrombin Generation after Therapy with Lipid-Lowering Drugs in High Cardiovascular Risk Subjects Supplemented with Folic Acid |
| Celinska-Lowenhoff M |
- |
Drug Induced Changes in Fibrin Clot Permeability in Patients with Coronary Artery Disease |
| Celinska-Löwenhoff M |
- |
Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia |
| Cellai AP |
- |
Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk |
| |
- |
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study |
| Cerbone AM |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| Cerbone AM |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| Cercignani M |
- |
Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers |
| Ceresa E |
- |
Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation |
| Ceresa E |
- |
A Rational Approach For Stabilization Of Activated TAFI (TAFIa) |
| |
- |
Characterization of ELISA's Exclusively Reacting with TAFI, the Released Activation Peptide from TAFI and Activated TAFI Using an in vitro Clot Lysis Assay |
| Ceresetto JM |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| |
- |
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation |
| Ceresetto JM |
- |
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE) |
| |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| Cerini C |
- |
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins |
| Cerletti C |
- |
Parnaparin Prevents the Upregulation of Platelet-Leukocyte Interaction in Whole Blood |
| |
- |
Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin |
| |
- |
Parnaparin Prevents Platelet-PMN Leukocyte Interaction: New Clues to the Antithrombotic Properties of Low Molecular Weight Heparin |
| |
- |
Leukocyte Activation in Myeloproliferative Disease |
| C[breve]erne M |
- |
New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold Antithrombotic Effect in Two Rat Venous Thrombosis Models |
| Cerny V |
- |
Treatment of Life Threatening Bleeding with rFVIIa in 20012004 in Czech Republic. Presentation of 126 Cases with the Help of UniSeven Registry |
| Cerqueira M |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease A Multi-Center Feasibility Study |
| Cerrato G |
- |
Comparison Among the New Immunoassays with Monoclonal Antibody Calibration and Home-Made Methods for Testing the Antiphospholipid Antibody (APA) Family |
| Cerrato G |
- |
Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation |
| Cerrato G |
- |
A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI) |
| Cerutti C |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| |
- |
Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions |
| Cesari F |
- |
Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC) |
| |
- |
Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis |
| |
- |
Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes |
| Cetin M |
- |
Thrombosis in Cancer Patients |
| Cetkovský P |
- |
Syndrome Kasabach-Merritt and Severe Postoperative Bleeding |
| Cha SH |
- |
Contribution of Thymidylate Synthase Enhancer Region (TSER) Polymorphism to Total Plasma Homocysteine Levels in Korean Patients with Recurrent Spontaneous Abortion |
| Chabielska E |
- |
Angiotensin 19 (Ang-1-9), Similarly to Angiotensin II (Ang II), Increases Blood Pressure and Enhances Thrombosis in Hypertensive Rats |
| Chabot F |
- |
Acquired Activated Protein C Resistance Associated with Pulmonary Arterial Hypertension Is Revealed by Calibrated Automated Thrombography |
| Chabrak S |
- |
Antiphospholipid Syndrome and Risk of Myocardial Infarction in Young: A Preliminary Study |
| Chackalamannil S |
- |
Antithrombotic Effects of SCH 205831: A Potent, Selective and Orally Active Antagonist of the PAR-1 Thrombin Receptor |
| Chacko C |
- |
The Crystal Structure of Unliganded Thrombin Identifies Regions Involved in Allosteric Regulation by Thrombomodulin |
| Chafa O |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Chagraoui A |
- |
S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4 |
| Chahwala S |
- |
Identification and in vitro Characterization of TGN 255, a Novel Synthetic Intravenous Low Molecular Weight Direct Thrombin Inhibitor |
| Chahwala S |
- |
The Utility of TGN 255 in a Model of Coronary Pulmonary Bypass and Simulated Mitral Valve Repair in the Dog |
| Chahwala S |
- |
Ecarin Clotting Time Profile of TGN 255, a Novel Synthetic Intravenous Direct Thrombin Inhibitor |
| |
- |
Anti-coagulant Activity of TGN 255, a Novel Synthetic Direct Thrombin Inhibitor |
| Chai X-Y |
- |
Alteration of Protein Z in Patients with Uremia and Its Significance |
| Chait P |
- |
Tissue Plasminogen Activator (TPA) Therapy Resulting in Epidural Haemorrhage Following Intrathecal Therapy in a Pediatric Patient with Stage IV Burkitt's Lymphoma |
| Chakravarthi P |
- |
Medroxyprogesterone Acetate-associated Relapse of Thrombotic Thrombocytopenic Purpura |
| Chakroun T |
- |
The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation |
| Chalabreysse L |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| Challier C |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Chalmers EA |
- |
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A |
| Chalmers E |
- |
A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia |
| Chalmers E |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Chalmers J |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Chalmers D |
- |
Ethical Dilemmas in Haemophilia Care |
| Chalmers EA |
- |
Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease |
| Chambers JP |
- |
Effects of Hypothermia and Acidosis on Swine Platelet Activation and Aggregation in vivo |
| Chamley L |
- |
Reversal of the Inhibitory Effect of Monclonal Antiphospholipid Antibodies on Trophoblast Proliferation by Unfractionated Heparin, Low Molecular Weight Heparins (Enoxaparin and Dalteparin) and a Synthetic Pentasaccharide, Fondaparinux |
| Chammas M |
- |
Prenatal Diagnosis in a Lebanese Family with Severe Factor VII Deficiency |
| Chamone DAF |
- |
D-Dimer Assay Used in the Diagnosis of Acute Venous Thromboembolism |
| |
- |
Thromboembolic Complications of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: Effects of the Disease and the Therapy on the Hemostatic System |
| |
- |
Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study |
| |
- |
Intraoperative Automatic Autotransfusion for Lung Transplantation |
| |
- |
Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report |
| |
- |
Heparin Induced Thrombocytopenia Type II In Cardiac Hemodialysis Brazilian Patients |
| |
- |
Oral Anticoagulation Laboratory Control: Comparison between Two Differents Methods |
| Chamone D |
- |
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis |
| Chamone DAF |
- |
Anticoagulation Therapy in the Osteonecrosis |
| Chamouard V |
- |
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor |
| Chamyan G |
- |
Thrombophilia, Placental Pathology and Perinatal Cerebral Infarction: Any Relationship? |
| Chan AKC |
- |
Effect of Mechanical Ventilation on the Hemostatic State of the Newborn |
| Chan |
- |
Roles of Arg257 and Arg1176 of ADAMTS13 in Its Proteolysis and Its Activity against VWF |
| Chan AKC |
- |
Dosing Regimen of rFVIIa for Orthopedic Surgery in Hemophilia with Inhibitor What Is the Right Dose? |
| |
- |
Reaction of Clot-Bound Thrombin with a Covalent Antithrombin-Heparin Complex Results in an Anticoagulant Surface |
| |
- |
Telephone Consultation Provided by the Hemophilia Treatment Centre A Significant Part of the Service |
| Chan A |
- |
Developmental Haemostasis and Response to Heparin Therapy in Children |
| Chan AKC |
- |
Utility of aPTT in Monitoring Unfractionated Heparin in Children |
| |
- |
Thrombosis in Paediatric Cancer Patients |
| Chan AK |
- |
Recurrent Stroke: The Role of Prothrombotic Disorders |
| Chan AKC |
- |
Analysis of Plasma Proteins Bound to Catheter Surfaces |
| |
- |
Comparison of Continuous and Subsampling Methods for Analysis of Thrombin Generation |
| Chan A |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| Chan AK |
- |
Immune Tolerance to Factor IX inhibitor |
| Chan AKC |
- |
Inhibition of Coagulation Cascade Enzymes by a Covalent Antithrombin-Heparin Complex |
| |
- |
Umbilical Vein Catheterization and Portal Vein Thrombosis in Neonates and Children: A Systematic Review with Meta-Analysis |
| Chan AK |
- |
Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B |
| Chan A |
- |
Heparin Monitoring During Haemodialysis in Children |
| Chan AKC |
- |
Comparison of Continuous and Subsampling Determination of Thrombin Generation in the Presence of Anticoagulants |
| Chan A |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU) |
| |
- |
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series |
| Chan AKC |
- |
Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children |
| |
- |
Biodistribution of a Covalent Antithrombin-Heparin Complex |
| Chan A |
- |
Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis |
| Chan Kwo Chion A |
- |
ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain |
| Chan2 R |
- |
The Generation of Thrombin by High Dose Recombinant Factor VIIa Can Be Mimicked by Lower Factor VIIa Concentrations Combined with Tissue Factor |
| Chander C |
- |
Pharmacodynamics of TGN 255, A Novel Intravenous Low Molecular Weight Direct Thrombin Inhibitor, in Healthy Subjects |
| |
- |
Pharmacokinetics and Pharmacodynamics of TGN 255, A Novel Intravenous Direct Thrombin Inhibitor in Healthy Volunteers. Comparison with Unfractionated Heparin |
| |
- |
Anti-coagulant Activity of TGN 255, a Novel Synthetic Direct Thrombin Inhibitor |
| |
- |
Ecarin Clotting Time Profile of TGN 255, a Novel Synthetic Intravenous Direct Thrombin Inhibitor |
| |
- |
Identification and in vitro Characterization of TGN 255, a Novel Synthetic Intravenous Low Molecular Weight Direct Thrombin Inhibitor |
| |
- |
The Utility of TGN 255 in a Model of Coronary Pulmonary Bypass and Simulated Mitral Valve Repair in the Dog |
| Chandler W |
- |
Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP) |
| Chandler A |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Chandler B |
- |
Regulation of CD154 (CD40L) and CD62 (p-selectin) Cell Surface Density May Be a Critical Mechanism in Conferring Proinflammatory and Prothrombotic Effects |
| Chandrakumaran K |
- |
Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery |
| Chandy M |
- |
Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate®DVI |
| |
- |
Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin |
| Chang C-S |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Chang N |
- |
Prothrombin Colocalizes to the Platelet Thrombus and Vessel Wall Interface after Laser Induced Thrombosis Injury |
| Chang M |
- |
Protein Profiling of Human Blood Platelets from Young and Aged Individuals |
| Chang Y |
- |
Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation |
| Changeux JP |
- |
Haemostasis Is Regulated through Nicotinic Acetylcholine Receptors |
| Chantarangkul V |
- |
Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations |
| |
- |
Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study |
| Chantarangkul V |
- |
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests |
| Chao T-Y |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Chaouki M |
- |
Increased Platelet CD36 Antigen: A Useful Marker of Myeloproliferative Disorders. Parallel Evolution to That of BCR-abelson Transcript in Chronic Myeloid Leukaemia |
| Chapman J |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| Chapman W |
- |
Safety, Immunogenicity, and Efficacy of Recombinant Human Thrombin as a Topical Surgical Hemostat: Integrated Results for a Multi-Surgery Phase 2 Program |
| Chapman J |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| Charles P |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| Charles Andrée Spector N |
- |
807C/T Polymorphism in the Platelet Glycoprotein Ia Gene in Patients with Ischemic Stroke (IS) of Undetermined Etiology |
| Charlesworth MC |
- |
Agonist Dependence of the Platelet Secretome |
| Charoenkwan P |
- |
Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency |
| Charron T |
- |
The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation |
| Chassany O |
- |
The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study |
| Chatamra K |
- |
Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice |
| Chatamra K |
- |
Clinical Measurements of Platelet Activation by Flow Cytometry Under Optimised Conditions |
| Chaudhary AGA |
- |
Prevalence of Genetic Risk Factors Causing Thrombophilia in Normal Population and Recurrent Abortions Patients in Saudi Arabia |
| Chaudhary RK |
- |
Influence of Pre Donation Donor Factors on the Yield of Platelets Using Intermittent Flow Cell Separators |
| |
- |
Quality Systems in Automated Plateletpheresis in Hospital Based Blood Transfusion Services in North India |
| Chauhan AK |
- |
Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice |
| Chavakis T |
- |
The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo |
| Chavez L |
- |
Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation |
| Chawla R |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| Cheesman EJ |
- |
A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C |
| Chellini B |
- |
More Carotid Atherosclerosis in HCV Positive Italian Patients? |
| Chen BG |
- |
Protein Tyrosine Kinase, Syk, Involved in Immune Platelet Phagocytosis, Also Plays a Role in Human Macrophage Cell-Cell Interactions and PECAM-1 Mediated Signal Transduction |
| Chen P |
- |
Platelet Aggregation Independent of Von Willebrand Factor and Fibrinogen |
| Chen D |
- |
Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection |
| Chen Y-H |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Chen HS |
- |
Complete Subunit Sequences and Glycan Structures of Factor X Activator from Russell's Viper Venom |
| Chen CM |
- |
Complete Subunit Sequences and Glycan Structures of Factor X Activator from Russell's Viper Venom |
| Chen F |
- |
Adjunctive Use of Anticoagulants with a TAFIa Inhibitor Does Not Further Enhance t-PA-Induced Thrombolysis in a Rabbit Arterial Thrombosis Model and Compromises Safety |
| Chen Y-C |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Chen J |
- |
aIIbb3 Binds a Site within the von Willebrand Factor (VWF) A1 domain: A Critical Role in Thrombus Formation |
| Chen D |
- |
Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury |
| Chen F |
- |
Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases |
| Chen PS |
- |
Pleiotropic Functions of Thrombomodulin Domains |
| Chen VMY |
- |
Mechanism of Activation of Tissue Factor |
| Chen Y |
- |
Prourokinase Activation Is the Speed-limited Step of Its Catalyzed Plasminogen Activation |
| Chen L |
- |
Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation |
| Chen Q |
- |
Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD) |
| Chen P |
- |
A Novel Anti-LIBS mcAb (3C7) Is Specific for the Complex of Integrin aIIbb3 and Inhibits Platelets Aggregation and Adhesion |
| Chen C-F |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Chen PS |
- |
Thrombomodulin Regulates Cell to Cell Junction Formation |
| Chen FP |
- |
The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells |
| Chen Y |
- |
The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells |
| Chen M |
- |
Effect of Alcohol on Intracellular PH in Human Umbilical Cord Blood CD34+ Stem Cells |
| Chen W |
- |
Effect of Alcohol on Intracellular PH in Human Umbilical Cord Blood CD34+ Stem Cells |
| Chen M |
- |
NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives |
| Chenaud C |
- |
Coagucheck aPTT versus Central Laboratory aPTT for Anticoagulation Management after Cardiopulmonary Bypass |
| Cheng S |
- |
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project |
| Cheng JT |
- |
Effect of YC-1, a cGMP-dependent Manner, on Heterotypic CellCell Interaction: The Study on Neutrophil-platelet Adhesion |
| Cheng S-N |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Cheng JC |
- |
Disabled-2 Is a Secreted Anti-adhesive Molecule During Platelet Activation and Aggregation |
| Chénier M |
- |
Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm |
| Chenou C |
- |
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate |
| Cheong PL |
- |
A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C |
| Cherkasova K |
- |
Platelet Activation during Stress in Hyperhomocysteinemic Rats |
| |
- |
Stress-Induced Platelet Activation in Hyperhomocysteinemic Rats |
| |
- |
Effects of Hyperhomocysteinemia on the Anticoagulant System and Platelet Function Under Stress |
| |
- |
Antiplatelet Effects of Hydroxyproline- and Proline-Containing Dipeptides |
| Chesterman CN |
- |
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly |
| |
- |
Thrombospondin as a Regulator of von Willebrand Factor Multimer Size |
| Chetty N |
- |
The Prevalence of the Human Glycoprotein PC-1 Gene Polymorphism (K121Q) and Its Association with Type II Diabetes and Insulin Resistance in the South African Inter Ethnic Population |
| |
- |
Platelet Glycoprotein IIIa (PlA1/A2) and Plasminogen Activator Inhibitor-1 (4G/5G) Polymorphisms as Risk Factors for Coronary Artery Disease |
| Chetty N |
- |
The Molecular Characterization of Apo E and Its Association with Serum and Platelet Membrane Lipids in Familial Hypercholesterolaemia (FH) |
| Cheung P |
- |
Circulating Tissue Factor Activity Is Increased by Hyperglycemia and Hyperinsulinemia in Normal Human Subjects |
| Cheveresan L |
- |
Thrombotic Risk in a Romanian Family with Protein S: Deficient Members |
| Cheveresan M |
- |
Thrombotic Risk in a Romanian Family with Protein S: Deficient Members |
| Chevreaud C |
- |
Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations |
| Chew H |
- |
Rates of Venous Thromboembolism (VTE) in Californians with Cancer |
| |
- |
Venous Thromboembolism in 68 142 Patients with Colorectal Cancer |
| Chhum S |
- |
The Affinity of Protein C for the Thrombin-Thrombomodulin Complex Is Determined in a Primary Way by Active Site-Dependent Interactions |
| Chi L |
- |
Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits |
| Chi HS |
- |
IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants |
| Chiang J-L |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Chibedi D |
- |
Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study |
| Chiles PG |
- |
Abnormal Kinetics of Fibrinolysis in Patients with Chronic Thromboembolic Pulmonary Hypertension |
| Chindemi PA |
- |
Biodistribution of a Covalent Antithrombin-Heparin Complex |
| Chin-Dusting J |
- |
Shear-dependent Role for Soluble P-selectin in Regulating Neutrophil Adhesion to Platelets |
| Chinni E |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Chintala M |
- |
Antithrombotic Effects of SCH 205831: A Potent, Selective and Orally Active Antagonist of the PAR-1 Thrombin Receptor |
| Chinthammitr Y |
- |
The Association of Prothrombin A19911G Polymorphism with Plasma Prothrombin Activity and Venous Thrombosis in a Large Population-Based Case-Control Study; Results of the MEGA Study |
| Chirinos JA |
- |
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions |
| Chironi G |
- |
Direct Flow Cytometry Counting of Circulating Endothelial Progenitor Cells in Whole Blood and Relationship with Cardiovascular Risk Factors |
| Chistolini A |
- |
Central Venous Catheters Related Thrombosis in Hematological Patients |
| Chitayat D |
- |
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family |
| Cho MR |
- |
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells |
| Cho L |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| Cho MR |
- |
The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction |
| Choi G |
- |
Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia |
| |
- |
Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs |
| Choi YK |
- |
Contribution of Thymidylate Synthase Enhancer Region (TSER) Polymorphism to Total Plasma Homocysteine Levels in Korean Patients with Recurrent Spontaneous Abortion |
| Choi DH |
- |
Contribution of Thymidylate Synthase Enhancer Region (TSER) Polymorphism to Total Plasma Homocysteine Levels in Korean Patients with Recurrent Spontaneous Abortion |
| Chong BH |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Chong AY |
- |
Increased Circulating Endothelial Cells in Acute Congestive Heart Failure: Comparison with von Willebrand Factor and Soluble E Selectin |
| Chong BH |
- |
Drug-induced Thrombocytopenia: Mapping of the binding Site of the Rifampicin-dependent Antibody on GPIX |
| Chong BH |
- |
Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Chong BH |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| Chong BH |
- |
The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice |
| |
- |
Autoimmune Thrombocytopenia |
| Choolani M |
- |
Systemic Pre-Operative Haemostatic Marker Levels and Their Association with Disease Outcome from Uterine Cervix and Endometrial Cancers Within 2 years |
| |
- |
Systemic Prognostic Haemostatic Marker Levels for Disease Outcome within Five Years from Ovarian Cancer |
| Choong S |
- |
Therapeutic Inhibition of Endothelial Tissue Factor Expression by Nitric Oxide and Other Agents in Sickle Transgenic Mice |
| Chopard C |
- |
Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis |
| Chorna N |
- |
The Effect of Fibrin Degradation Products on Neuroendocrine Cells |
| Chotisupakarn S |
- |
Spontaneous Subgaleal Hemorrhage in a Girl with Adrenaline Receptor Defect |
| Chou E |
- |
Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B |
| Choudhury A |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| Chow T |
- |
Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States |
| Chrenek P |
- |
Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development |
| Chrétien MH |
- |
Protein Z Polymorphisms and Cerebral Venous Thrombosis |
| |
- |
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report |
| |
- |
Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia |
| Christella M |
- |
Effect of Oral Contraceptives on the Anticoagulant Activity of Protein S in Plasma |
| Christensen JH |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| |
- |
Plasma Lipids and Lipoproteins in Healthy Subjects are Closely Related to INR |
| Christensen H |
- |
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family |
| Christensen K |
- |
Cerebral Venous Sinus Thrombosis in a 12 year Old Boy with Transient Antiphospholipid Antibodies |
| Christensen JH |
- |
Atorvastatin Treatment Affects Vitamin K-Dependent Coagulation Factors (INR) In Patients With Coronary Heart Disease |
| Christensen K |
- |
12-Year Old Boy with Deep Venous Thrombosis (DVT) and Pulmonary Thromboembolism (PTE) |
| Christensen H |
- |
Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy |
| Christensen SE |
- |
Effects of Acidosis and Hypothermia on Whole Blood Clotting Function in Swine |
| Christensen K |
- |
Orthopedic Outcome in Patients With Severe Hemophilia Under Prophylactic TreatmentBenefit of an Early Long-term Prophylaxis? |
| Christersson C |
- |
Persistently Reduced D-dimer Levels by the Oral Direct Thrombin Inhibitor Ximelagatran Indicate Reduced Risk of New Ischemic Events after Myocardial Infarction |
| Christersson C |
- |
IL-10 Inhibits TF mRNA and the Surface Expression of TF in Platelets-monocytes Aggregates In Stimulated Whole Blood |
| Christian WH |
- |
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets |
| Christiansen K |
- |
Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A |
| |
- |
Visualization of the Continuous APTT Coagulation Signature Methods and Correlations to Continuous Thrombin Generation |
| |
- |
The Whole Blood Coagulation Profile in Hyperhomocysteinemic Patients with Prior Thrombosis is Changed by Folic Acid Treatment as Evaluated by roTEG Thrombelastography |
| Christiansen SC |
- |
Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study |
| Christie D |
- |
High Shear Platelet Function Is Associated with Major Adverse Events in Patients with Stable Cardiovascular Disease (CVD) Despite Aspirin Therapy |
| Christie BA |
- |
Intra-Articular Hylan GF 20 (Synvisc®) in the Treatment of Hemophilic Arthropathy |
| Christine H |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Christodoulos K |
- |
Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer |
| Christopherson P |
- |
Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF |
| ChristopoulouCokkinou V |
- |
How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals? |
| Chroust K |
- |
Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine Prospective Survey |
| Chrzanowska-Wodnicka M |
- |
Rap1b Is Required for Normal Blood Vessel Formation in Mice |
| Chtourou S |
- |
Efficiency of TSE Elimination By Coagulation Factor Manufacturing Processes |
| Chtourou S |
- |
A Comparison of Two Manufacturing Processes for an Antithrombin Concentrate |
| |
- |
Evaluation of a New Manufacturing Process for Therapeutic Fibrinogen |
| Chtourou S |
- |
Nanofiltration's Contribution to Coagulation Factor Safety |
| Chu H-l |
- |
Carrier Detection and Prenatal Diagnosis on Hemophilia |
| Chu K |
- |
Characterization and Gene Silencing of a Novel Gla-Containing Protein |
| Chuansumrit A |
- |
Acute and Long Term Management for Patients with Severe Protein C Deficiency |
| Chuansumrit A |
- |
Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency |
| Chudasama V |
- |
Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography |
| |
- |
Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation |
| Chudzinski-Tavassi AM |
- |
Identification of New Secreted Proteins from Haementeria Depressa Leech Salivary Complexes by Transcriptomic and Proteomic Analysis |
| |
- |
Exploring New Molecules and Activities from Lonomia Obliqua Caterpillar Bristles Extract |
| |
- |
Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor |
| Chuen CKY |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| |
- |
The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production |
| Chukhlovina M |
- |
The 4g/5g Polymorphism of the Pai-1 Gene is Associated with Cerebrovascular Disease Development in Childhood and Juvenile Period |
| Chun Fan |
- |
Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells |
| Chung HJ |
- |
Cardioprotective Effect of KR-32568, a Novel Sodium/hydrogen Exchanger-1 Inhibitor, in a Rat Model of Ischemia and Reperfusion Heart Injury |
| Chung K |
- |
A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking |
| Chung C-Y |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Chung F |
- |
A Sequence Derived from Loop I of PDGF Inserted into Neurotoxin Dendroaspin Scaffold Has an Ability to Inhibit Cell Proliferation and Migration |
| |
- |
Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins |
| Chunilal S |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Chunilal SD |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| Church FC |
- |
Site-Directed Mutagenesis of the Alpha-1 Protease Inhibitor D-helix to That of Heparin Cofactor II Confers Heparin Specific Properties |
| |
- |
Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin |
| |
- |
Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN) |
| |
- |
Role of the Protein C System in Endothelial and Breast Cancer Cell Migration |
| Chyczewski L |
- |
Plasmatic and Urinary Tissue Factor (TF) And Its Inhibitor (TFPI) Do Not Reflect the Activity of Human Chronic Glomerulonephritis |
| Chyna B |
- |
Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS |
| |
- |
Tissue Factor Mediated Activation of Prothrombin Complex Concentrates and Its Inhibition by Anti-Thrombin Drugs |
| |
- |
Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology |
| Chytra I |
- |
Special Hemocoagulative Examination at Invasive Meningococcal Disease |
| Ciabattoni G |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| |
- |
Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria |
| |
- |
Insulin Resistance and Platelet Activation in Obese Women |
| Ciampa A |
- |
Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR |
| Ciani F |
- |
Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers |
| Cichon M |
- |
Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology |
| Cid AR |
- |
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations |
| Cid AR |
- |
von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre |
| Cid AR |
- |
Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit |
| Cid A |
- |
Optimisation of Ristocetin Cofactor Test for Low Activity Samples |
| Cid AR |
- |
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects |
| Cierniewski CS |
- |
Activation of NF-kB by Reactive Oxygen Species Mediates Induction of PAI-1 Expression in Vascular Endothelial Cells |
| |
- |
Adhesive Properties and Fibrinolytic Response of Endothelial Cells Containing PAI-1 in the Complex with Alpha 1-Acid Glycoprotein Accumulated on Their Surface |
| |
- |
Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors |
| |
- |
Binding Sites for PAI-1 Are Exposed in Fibrin But Not in Fibrinogen |
| |
- |
Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit |
| |
- |
Refolding Characteristics of Recombinant Beta3(109-352) Fragment and Formation of a Functionally Active A-Domain |
| |
- |
Expression of GPVI Is Modulated in Endothelial Cells by Different Agonists |
| Cieslikiewicz D |
- |
Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines |
| Cimino E |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| Cimmino G |
- |
Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes |
| Cimo M |
- |
Strong Lupus Anticoagulant (LA) Appears to Interfere with Activated Protein C Resistance Assay (APCR) |
| Cini M |
- |
Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal |
| |
- |
Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels |
| |
- |
D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| |
- |
D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| Cinotti S |
- |
Long Term and Low Dose Prophylaxis with rFVIIa in Patients Affected by Congenital Bleeding Disorders |
| Cipolla N |
- |
Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders |
| Cipolla A |
- |
Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease |
| |
- |
Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors |
| |
- |
Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa |
| |
- |
First Line Therapy with FEIBA® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors |
| CipollaD'Arpa AS |
- |
Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk |
| Cipriano A |
- |
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature |
| Cirillo F |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| Cisowski M |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Cisterna B |
- |
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with  -Related Disease |
| Citkowicz A |
- |
Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein |
| Ciuti G |
- |
The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective CaseControl Study |
| |
- |
Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study |
| Claeys MJ |
- |
Pretreatment with Aspirin and Loading Dose Clopidogrel Obviates the Need for Glycoprotein Iib/Iiia Antagonists During Elective Coronary Stenting |
| Clark S |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| Clark P |
- |
Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis |
| Clark D |
- |
In Vitro Stability of Dilutions of the Recombinant Factor VIII Kogenate FS for Continuous Infusion Use |
| Clark P |
- |
ABO and Secretor Genotypes and the Risk of Pre-Eclampsia |
| Clark M |
- |
Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera |
| Clarke S |
- |
Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study |
| Clarke MC |
- |
Apoptotic Mechanisms Underlying High-Risk Plaque |
| Class D |
- |
Cranial Epidural Bleeding in a Child with Congenital Afibrinogenaemia, Management and Long-Term-Prophylaxis with a Fibrinogen Concentrate |
| Claus D |
- |
Prospective Investigations of the Predictive Value of hs-CRP in Patients with and without the Presence of Antiphospholipid Antibodies |
| Clauser S |
- |
Elevated Gas6 Plasma Levels in Patients with Severe Sepsis |
| Clavreul N |
- |
Silencing of Plasminogen Activator Inhibitor-1 by Small Interfering RNA Increases the Expression of Tissue Plasminogen Activator |
| Claxton A |
- |
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial |
| Clemetson KJ |
- |
A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia |
| Clemetson JM |
- |
Snake Venoms and Haemostasis |
| Clemetson KJ |
- |
Snake Venoms and Haemostasis |
| Clemetson KJ |
- |
Role of GPIb, GPIIb/IIIa and Shear on COAT-Platelets Formation |
| Clerici C |
- |
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement |
| Clerici M |
- |
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests |
| Clerin V |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Clerin V |
- |
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice |
| Clohisy DR |
- |
Intra-Articular Hylan GF 20 (Synvisc®) in the Treatment of Hemophilic Arthropathy |
| Clongstaff C |
- |
Prothrombin Binding to Phospholipid Membranes A Proposed Mechanism |
| Cloutier S |
- |
Efficacy of the PFA-100® as a Screening Tool for Platelet Dysfunction |
| |
- |
Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy |
| Cludts K |
- |
Activation and Translocation of Tyrosine Phosphatase SHP-1 to Lipid Rafts Is P2X1 Mediated: Role in Collagen Induced Platelet Activation |
| Clutterbuck R |
- |
Platelet-Derived Microparticles Bind Heparin with High Affinity |
| |
- |
Hypertonic Stress Alters the Yield and Type of Microparticles Produced by Haemopoietic Cells |
| Clutterbuck R |
- |
Heterogeneity of Integrin Expression on Platelet Microparticles. Use of A Snake Venom Disintegrin as a Functional Probe |
| |
- |
Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages |
| |
- |
Identification of Genes Regulated by Oxidised LDL Acting Through Scavenger Receptor CD36 in Transfected HEK293 Cells |
| CN Andrade |
- |
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital |
| Cobain TJ |
- |
Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates |
| Cobb R |
- |
Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM) |
| Cocci F |
- |
Aspirin-Clopidogrel Combination and Trans-Esophageal Echo Parameters Predictive of Thromboembolism in Atrial Fibrillation: The CLAAF-Pilot Study |
| Cochery-Nouvellon E |
- |
Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C |
| |
- |
The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched CaseControl Big NOHA First Study |
| Cochrane A |
- |
Monitoring Haemostasis in Cardiopulmonary Bypass in Children Measures of Heparin Activity |
| |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children |
| |
- |
Platelet Changes during Cardiopulmonary Bypass in Children |
| Cockerill PN |
- |
Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression |
| Coen D |
- |
Ischemic Childhood Stroke and Lipoprotein (a) |
| Coen M |
- |
Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis |
| Coen Herak D |
- |
Is it Possible to Predict the Degree of FVIII Deficiency from aPTT Waveform Analysis on Behring Coagulation Timer (BCT) |
| Coen Herak D |
- |
Improvement of STA: STACLOT APC-R Test for the Detection of Factor V Leiden by Using APCR Ratio |
| Coetzee M |
- |
Development of Antithrombotic Antibodies to Human Tissue Factor |
| Coghlan D |
- |
An Audit on D-dimer Use in the Assessment of Patients with Suspected Acute Pulmonary Embolism |
| Cohen H |
- |
Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring |
| |
- |
Implementation of a Telematic Homecare Platform for Oral anticoagulant Management |
| Cohen AT |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| Cohen M |
- |
Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI) |
| Cohen A |
- |
ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study |
| Cohen AT |
- |
Effectiveness of Anticoagulant Thromboprophylaxis in Medical Diagnostic/Speciality Subgroups: A Meta-Analysis of Randomised Clinical Trials |
| Cohen H |
- |
ADAMTS13 Gene Mutations and Polymorphisms in Acquired Thrombotic Thrombocytopenic Purpura (TTP) Patients |
| Cohen AT |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Cohen A |
- |
Thromboprophylaxis in Medical Patients with an Acute Medical Illness (Excluding Stroke and Myocardial Infarction): A Meta-analysis |
| Cohen ER |
- |
Atorvastatin Delays Thrombus Formation and Inhibits Leukocyte-Firm Adhesion to Thrombi Following Laser-Induced Arterial Injury in the Mouse |
| Cohen H |
- |
Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura |
| |
- |
A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing |
| Cohen AT |
- |
Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years |
| Cohen H |
- |
Treatment of HIV Associated Thrombotic Thrombocytopenic Purpura-Importance of Prompt Diagnosis |
| Cohen AT |
- |
Risk Factors for VTE In Patients Undergoing Abdominal Surgery: Lessons from the PEGASUS Trial |
| Colaizzo D |
- |
The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia |
| Colaizzo D |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Colbatzky F |
- |
Anticoagulant, Anti-inflammatory and Organoprotective Effects of BIBT 986, a Novel Dual Inhibitor of Thrombin and Factor Xa, on LPS-induced Disseminated Intravascular Coagulation and Septicemia in the Rat |
| Cole SA |
- |
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS) |
| Cole VJ |
- |
Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke |
| Cole K |
- |
Coagulation Activation in Women with Hyperemesis Gravidarum |
| Cole V |
- |
Hormonal Regulation of the Anticoagulant Protein S |
| Coleman M |
- |
Effective Venous Thromboembolic Risk Assessment in Pregnancy Allows Appropriate Thromboprophylaxis: a Prospective Outcomes Study |
| Colle S |
- |
TECHNOZYM® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13 |
| Collen D |
- |
Plasma Levels of Gas6 and its Soluble Receptors In Severe Sepsis: Diagnostic and Prognostic Implications |
| |
- |
Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium |
| |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| |
- |
Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity |
| Colliec-Jouault S |
- |
Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells |
| |
- |
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model |
| Collins P |
- |
The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication |
| Collins P |
- |
The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia |
| Collins J |
- |
Regulation of Platelet P2Y1 and P2Y12 Purinergic Receptor Internalization |
| Collins P |
- |
The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH) |
| |
- |
Detection of Decreased GPIb Alpha Expression Using an Improved Flow Cytometric Assay in Pateints with an Inherited Macrothrombocytopenia and a Mild Clinical Phenotype |
| |
- |
Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) A UK National Study |
| Collot S |
- |
Identification of Genes Regulated by Oxidised LDL Acting Through Scavenger Receptor CD36 in Transfected HEK293 Cells |
| Collot Sophie |
- |
Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells |
| Collot-Teixeira S |
- |
Macrophage Gene Expression Appears to Differ between AGE and OxLDL Stimulation |
| Collot-Teixeira S |
- |
Gene Expression Comparison Between Monocytes in Culture and Atherosclerotic Laser Microdissected Resident Macrophages |
| Colman RF |
- |
Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop |
| Colman RW |
- |
Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop |
| Colman RW |
- |
The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo |
| Colman S |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Colman RW |
- |
High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells |
| Colman RW |
- |
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis |
| Colman RW |
- |
Thrombin Regulates cAMP Level in Human Platelets through Phosphorylation/Activation of Akt |
| |
- |
Activated Peripheral Mononuclear Cells Plus Soluble Plasma Tissue Factor (TF) Activate Factors VII and X in Cardiac Surgical Wounds |
| Colorado M |
- |
Hemostatic Abnormalities in Oncolgic Patients |
| Colorado M |
- |
Vein Trombosis in Pediatric Patients |
| Colucci G |
- |
Role of GPIb, GPIIb/IIIa and Shear on COAT-Platelets Formation |
| Colucci M |
- |
Evidence Suggesting That Activated Platelets Induce APC-Resistance in Vivo |
| Colucci G |
- |
Effects of Temperature and Shear on COAT-Platelets Generation |
| Colucci G |
- |
Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis |
| Colucci M |
- |
APC Resistance Caused by Prothrombin G20210A Mutation Does Not Affect the Fibrinolytic Activity of Activated Protein C |
| Colucci G |
- |
Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Activation |
| Colucci M |
- |
Platelets Abolish the Profibrinolytic Effect of Heparin but not That of Melagatran |
| Colucci G |
- |
ADAMTS13 Is Present in Human Platelets and Strongly Expressed on COAT-Platelets |
| Colwell CW |
- |
FLEXTRA: Early vs Delayed Initiation of Postoperative Fondaparinux Prophylaxis after Joint Replacement: A Clinical Outcome Study |
| |
- |
Self-Injection of Fondaparinux (Arixtra®) in the Prophylaxis against Venous Thromboembolism after Major Orthopedic Surgery is Well Accepted, Effective, and Safe: Data from the FLEXTRA Trial |
| Colwell Jr. CW |
- |
Fatal Vascular Outcomes Following Major Orthopedic Surgery |
| Combe S |
- |
Pharmacokinetics of TGN 255, a Novel Intravenous Low Molecular Weight Direct Thrombin Inhibitor, in Healthy Volunteers |
| |
- |
Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis |
| |
- |
Pharmacokinetics and Pharmacodynamics of TGN 167, a Novel Oral Direct Thrombin Inhibitor in Healthy Volunteers |
| |
- |
Pharmacokinetics and Pharmacodynamics of TGN 255, A Novel Intravenous Direct Thrombin Inhibitor in Healthy Volunteers. Comparison with Unfractionated Heparin |
| |
- |
Pharmacodynamics of TGN 255, A Novel Intravenous Low Molecular Weight Direct Thrombin Inhibitor, in Healthy Subjects |
| Combot C |
- |
A New Fully Automated Functional Assay for TAFI Determination STA® Stachrom® TAFI |
| Combrié R |
- |
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets |
| Comeglio M |
- |
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease |
| Comfurius P |
- |
Phosphatidylserine Exposure During Platelet Stimulation Is Caused by Activation of Scramblase and Inactivation of Aminophospholipid Translocase in a Distinct Platelet Fraction |
| Comp P |
- |
Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study |
| Compernolle G |
- |
Expression and Characterization of Rat TAFI |
| |
- |
Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation |
| Compes M |
- |
Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations |
| Comuzzie AG |
- |
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS) |
| Conard J |
- |
Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect |
| |
- |
Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists |
| |
- |
Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation |
| |
- |
Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens |
| |
- |
Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History |
| Conard J |
- |
Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis |
| Conard J |
- |
Pregnancy-associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both |
| |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| |
- |
Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations |
| |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| |
- |
Pregnancy-Associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both |
| |
- |
A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance |
| Concolato A |
- |
Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study |
| |
- |
Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study |
| Conkie J |
- |
Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study |
| Conlan MG |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| Conley PB |
- |
Regulation of Platelet P2Y1 and P2Y12 Purinergic Receptor Internalization |
| Connor DE |
- |
The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting |
| |
- |
Methodological Issues Which May Influence the Detection, Quantitation and Functional Assessment of Platelet-Derived Microparticles |
| Connor M |
- |
Pilot Study: Aspirin Resistance and/or Platelet Hypersensitivity in Cerebrovascular Disease |
| Connor DE |
- |
Procoagulant Phospholipid Activity Associates Not Only with Free Microparticles, But with Platelets and/or Microparticles Complexed to Erythrocytes and Leukocytes |
| Conradi A |
- |
Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study |
| Consiglio P |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| Consoli A |
- |
MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes |
| Constantopoulos S |
- |
Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism |
| Conti S |
- |
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients |
| Conti AA |
- |
Inflammatory Markers are Associated with the Abdominal Aortic Diameter |
| Conti S |
- |
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial |
| Conway EM |
- |
Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium |
| Conway EM |
- |
New Insights into Angiogenesis-Dependent Disease Processes |
| Cook PM |
- |
TAFIa Treatment of High Molecular Weight Fibrin Degradation Products Reduces the Ability of Plasminogen to Protect tPA from Inhibition by PAI-1 |
| Cook SA |
- |
Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage |
| Cooke VG |
- |
Essential Role of Junctional Adhesion Molecule-A in bFGF-Induced Angiogenesis |
| Cooley SM |
- |
The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population |
| Coombs CJ |
- |
Brachial Artery Thrombosis in Infants: A Multidisciplinary Algorithm for Limb Salvage |
| Cooper PC |
- |
Reproducibility of the Endogenous Thrombin Potential by Calibrated Automated Thrombogram Assay |
| Cooper JA |
- |
Fibrinogen May Predict Death from Cancer in Men with Lower Extremity Arterial Disease |
| Cooper PC |
- |
Influence of Factor V Leiden and Lupus Anticoagulant on a New Venom-Based Clotting Assay of Protein C |
| Cooper SM |
- |
Influence of Factor V Leiden and Lupus Anticoagulant on a New Venom-Based Clotting Assay of Protein C |
| Cooper A |
- |
Quantitation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Human Semen |
| |
- |
Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease? |
| |
- |
Does Human Semen Contain a Functional Haemostatic System? A Possible Role for Tissue Factor Pathway Inhibitor in Fertility through Semen Liquefaction |
| Cooper JA |
- |
Risk Factors for Central Retinal Vein Occlusion |
| |
- |
Persistent Hypercoagulability and Risk of Cancer in Older Men |
| |
- |
Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study |
| Cooper ST |
- |
Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin |
| Cooper SM |
- |
Evaluation of a New Factor Xa-based Antithrombin assay |
| Cooper PC |
- |
Evaluation of a New Factor Xa-based Antithrombin assay |
| Cooper A |
- |
Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen? |
| Coppens M |
- |
The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia |
| |
- |
Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study |
| Coppens M |
- |
Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation A Prospective Cohort Study |
| |
- |
Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c |
| |
- |
A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism |
| Coppo M |
- |
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease |
| Coppola A |
- |
Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance |
| Coppola R |
- |
TAFI 325/Ile Genotype in Old Population of Northern Italy |
| Coppola A |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| Coppola A |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| Coppola A |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| Coppola R |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Coppola A |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| Corash L |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| |
- |
The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Three European Blood Centers |
| Corazzi T |
- |
Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes |
| Corbière C |
- |
S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4 |
| Corbin J |
- |
Molecular Dissection of Platelet Production Via Random Mutagenesis |
| Cordova R |
- |
Different Thromboprophylaxis Approaches in Patients Undergoing Knee Arthroscopy (KANT Study): A Prospective Randomized Study |
| Corinaldesi G |
- |
Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Events after Myocardial Infarction |
| Corinaldesi C |
- |
Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Events after Myocardial Infarction |
| Corinaldesi G |
- |
Heparin Induced Thrombocytopenia (HIT) in Recurrent Acute Thrombophlebitis in Cancer Patients: Killer Clot, or Killer Drugs |
| Corinaldesi C |
- |
Heparin Induced Thrombocytopenia (HIT) in Recurrent Acute Thrombophlebitis in Cancer Patients: Killer Clot, or Killer Drugs |
| Corinaldesi G |
- |
Giant Cells Thrombocytopenia MYH9-Related, Management of Mild/Moderate Bleeding Episodes |
| Corinaldesi C |
- |
Giant Cells Thrombocytopenia MYH9-Related, Management of Mild/Moderate Bleeding Episodes |
| Corinaldesi G |
- |
Carotid Plaque and Hypercoagulability Are Strong Risk Factors for Ischemic Stroke |
| Corinaldesi C |
- |
Carotid Plaque and Hypercoagulability Are Strong Risk Factors for Ischemic Stroke |
| Cornelli U |
- |
Protamine Sulfate Is Capable of Neutralizing Bacterial Core Polysaccharide Derived Sulfaminoheparosans |
| |
- |
Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats |
| |
- |
Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects |
| |
- |
Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis |
| Cornillon J |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| Corno AR |
- |
Automated VWF : RCo for VWD Diagnosis |
| Cornuz J |
- |
Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score |
| |
- |
Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cut-Off Value in Outpatients with Suspected Pulmonary Embolism |
| Corral J |
- |
Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction |
| |
- |
Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis |
| |
- |
Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction |
| |
- |
Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic? |
| |
- |
Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A2 Level and might Affect the Efficacy of Aspirin |
| |
- |
Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome |
| |
- |
Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus |
| |
- |
Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy |
| |
- |
Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone |
| |
- |
Conformational and Functional Changes in Antithrombin by Oxidation |
| |
- |
Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage |
| |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| |
- |
Pharmacogenetic Effect of Factor VII -323 Del/Ins Polymorphism on Diurnal Variation of Factor VII Coagulant Activity and INR in Steady Anticoagulated Patients with Atrial Fibrillation |
| |
- |
Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder |
| Corrocher R |
- |
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism |
| |
- |
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project |
| Corsi AM |
- |
Vitamin B6 Serum Level and Inflammation and in the InChianti Study |
| |
- |
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study |
| |
- |
MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study |
| |
- |
Inflammatory Markers are Associated with the Abdominal Aortic Diameter |
| |
- |
Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study |
| Cortina V |
- |
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects |
| Cortina V |
- |
Optimisation of Ristocetin Cofactor Test for Low Activity Samples |
| Cortina V |
- |
Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit |
| |
- |
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations |
| Corvazier E |
- |
A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis |
| Cosemans JMEM |
- |
Roles of Platelet ADP and Gas6 Receptors in Thrombus Stability |
| Cosmi B |
- |
Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal |
| |
- |
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized Prolong Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) |
| |
- |
Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels |
| Cosmi B |
- |
D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| |
- |
D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| Costa MC |
- |
Heparin Induced Thrombocytopenia Type II In Cardiac Hemodialysis Brazilian Patients |
| Costa JM |
- |
13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population |
| Costa C |
- |
Haemophilia B in Female |
| Costa FF |
- |
Molecular Analysis of Two Unrelated Patients with Bernard-Soulier Syndrome Identification of Novel Mutation in Glycoprotein Ib Alpha Gene |
| Costa F |
- |
Contortrostatin: A Potent Inhibitor of Cancer Growth and Angiogenesis |
| Costanzo M |
- |
Antiaggreganting Agents Do Not Influence the Sonoclot Profile |
| |
- |
Managed Hemostasis Point-Of-Care Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests |
| |
- |
High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study |
| Cotrina R |
- |
Optimal Oral Anticoagulation Therapy and Major Bleeding in Patients with Heart Diseases in a Peruvian Heart Institute |
| Cottini S |
- |
Coagucheck aPTT versus Central Laboratory aPTT for Anticoagulation Management after Cardiopulmonary Bypass |
| Coughlin SR |
- |
Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis |
| Cournoyer D |
- |
Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States |
| Coutinho A |
- |
Ischemia/Reperfusion Induces the Binding of Circulated Immunoglobulins to Blood Vessels |
| Couturad F |
- |
Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study |
| Couturaud F |
- |
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based CaseControl Study |
| |
- |
Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study |
| |
- |
Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study |
| Couturaud F |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| Couvret C |
- |
Development of Non-pathogenic Antibodies to Platelet Factor 4 during Treatment by Fondaparinux after Hip Surgery |
| Couzens S |
- |
Detection of Decreased GPIb Alpha Expression Using an Improved Flow Cytometric Assay in Pateints with an Inherited Macrothrombocytopenia and a Mild Clinical Phenotype |
| Covic L |
- |
The Effect of a Second Generation Inhibitor of p38 MAP Kinase on Platelet Function |
| Cox D |
- |
Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation |
| Cox DM |
- |
A Comparison of the Effects of Shear Stress on the Interactions between Streptococcus sanguis and Staphylococcus aureus with Perfused Human Blood Platelets |
| Cox D |
- |
Multiple Mechanisms for S. Aureus and S. Epidermidis Platelet Activation |
| Cox P |
- |
No Difference in Incidences of Thrombosis between Heparin Bonded Catheters and Non Heparin Bonded Catheters in Infants in the Critical Care Unit Following Surgery for Congenital Heart Disease: A Randomised Controlled Triple Blind Study |
| Cox D |
- |
Development of a Mouse Serum Protein Map for Proteomic Research |
| Coyle L |
- |
Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients |
| |
- |
Use of a Functional Assay to Diagnose Protein S Deficiency; Increasing Testing of Obstetric Patients Yields Unreliable Results |
| |
- |
To Mix with Pooled Normal Plasma or Not to Mix: A Comparative Study of Two Approaches to Assessing Lupus Anticoagulant Inhibitory Activity in the Dilute Russell Viper Venom Method |
| Coyne S |
- |
The Palmitolyated Cysteine 595 Residue of PECAM-1 Is Required for Constitutive Association of PECAM-1 into Membrane Microdomains |
| Coyne E |
- |
Fish Skins as a Source of Heparin-Like GAGs |
| Cozzi MG |
- |
Evaluation of the New ACL TOP Coagulation Analyser from IL |
| Cozzi MR |
- |
Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit |
| Cozzi E |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Cozzi MR |
- |
Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow |
| Craciun A |
- |
Associated Vitamin K Deficiency in Gaucher Disease Patients |
| Craig D |
- |
Detection of Activated Factor XII Associated with Blood Cells in Both FXII Normal and FXII Deficient Subjects |
| Crain E |
- |
Razaxaban, a Novel Direct Factor Xa Inhibitor, Enhanced the Antithrombotic Effects of Aspirin and Clopidogrel But Not Their Bleeding Time Effects in Rabbits |
| |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| |
- |
Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis |
| Cramer EM |
- |
HZF as a Candidate Gene for Gray Platelet Syndrome (GPS) |
| |
- |
Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes |
| Cramer EM |
- |
Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation |
| Cramer E |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Cramer EM |
- |
A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C |
| Crandall D |
- |
Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis |
| Crandall DL |
- |
A Novel Method for Determination of Human Plasma Plasminogen Activator Inhibitor (PAI-1) |
| Crandall DL |
- |
Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290 |
| Cranford LC |
- |
Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN) |
| Craven S |
- |
Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations? |
| Craven SJ |
- |
Platelets Provide Factor IX (FIX) and Factor X (FX) to Support Dilute Tissue-factor Dependent Coagulation |
| |
- |
Probable Involvement of Endogenous Platelet Protease(s) in PAR-Dependent Platelet Activation |
| |
- |
Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin |
| Crawford GL |
- |
O-GlcNAc Cycling Is Important for Regulated Platelet Exocytosis |
| Crawley JTB |
- |
Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP) |
| Crawley JTB |
- |
Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression |
| |
- |
Roles of Arg257 and Arg1176 of ADAMTS13 in Its Proteolysis and Its Activity against VWF |
| |
- |
ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain |
| Crean CS |
- |
Phase 1 Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of a Novel Rapidly Reversible Intravenous Platelet P2Y12 ADP Receptor Antagonist, INS50589 |
| Cree A |
- |
Venous Thromboembolism and Spinal Surgery |
| Cremona LS |
- |
Clinical Audit of Thromboembolism Prophylaxis 3 years after the 6th ACCP Report in a Tertiary Care Hospital in Córdoba, Argentina |
| Cremonesi M |
- |
The G1691A Factor V and G20210A Prothrombin Gene Mutations Are Not Associated to an Increased Risk of Venous Thromboembolism (VTE) in Patients with Gastrointestinal (GI) Carcinoma |
| Crescenzio N |
- |
Hemostatic Alterations in Pediatric Leukemias |
| Crippa L |
- |
LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®) |
| Crittenden JR |
- |
CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets |
| Crookston K |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| |
- |
D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius |
| Crosby D |
- |
PKCalpha Coordinates Syk and Src Signalling in Human Platelets |
| Crosdale DJ |
- |
Evidence of Partial P2Y12 Receptor Antagonism Despite Excess Clopidogrel in Mice |
| Crotti S |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| Crowther M |
- |
Measurement of EQA Performance of a Whole Blood D-Dimer Assay Using Lyophilized Plasma |
| Crowther MA |
- |
Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis |
| Crowther M |
- |
A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves |
| |
- |
A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes |
| Crudder S |
- |
Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis |
| |
- |
Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders |
| |
- |
Multi-Site Comparison of Platelet Function Testing |
| Cruz MA |
- |
aIIbb3 Binds a Site within the von Willebrand Factor (VWF) A1 domain: A Critical Role in Thrombus Formation |
| Csóti E |
- |
Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease |
| Ctercteko G |
- |
Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Elective Colorectal Surgery |
| Cubillo P |
- |
Decreased Plasma Levels of Activated Protein C in Young Survivors of Myocardial Infarction: Relationship with the Extent of Coronary Artery Disease |
| Cueto C |
- |
Characterization and Performance of the HemosIL Silica Clotting Time (SCT) Test for Detection of Lupus Anticoagulants |
| Cugno M |
- |
Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation |
| Cui J |
- |
The Impact of Factor XIII Polymorphisms, FXIIIa T204P, P506L and Factor XIIIb Polymorphism H95A, on Myocardial Infarction |
| |
- |
Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency |
| Cui Y |
- |
Construction of a Phage Display Library of Human Fab Antibodies against Human Platelet Membrane Glycoprotein IIb/IIIa |
| Cuisset T |
- |
Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting |
| Culakova E |
- |
Risk Factors for Chemotherapy-Associated Venous Thromboembolism in a Prospective Observational Study: A Proposed Predictive Model |
| |
- |
Elevated Platelet Count Increases the Risk of Thromboembolism during Outpatient Chemotherapy |
| Cullen J |
- |
Rap1b Is Required for Normal Blood Vessel Formation in Mice |
| Culligan K |
- |
A Novel Integrin aIIbb3-Associating Protein in Platelets |
| Culligan K |
- |
Proteomic Analysis of The Low Molecular Weight Platelet Secretome Reveals the Presence of Novel N-Terminal Thrombospondin-1 Fragments |
| Culligan KG |
- |
Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes |
| Cultrera D |
- |
Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders |
| |
- |
Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk |
| |
- |
Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease |
| |
- |
Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors |
| |
- |
Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa |
| |
- |
First Line Therapy with FEIBA® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors |
| Cummine J |
- |
Venous Thromboembolism and Spinal Surgery |
| Cumming A |
- |
Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) A UK National Study |
| Cunanan J |
- |
Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin |
| |
- |
Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay |
| |
- |
Ex vivo Evaluation of the Pharmacodynamic Effects of Defibrotide. Results from Various Clinical Trials |
| |
- |
Comparison of the Anticoagulant Properties of BAY 59-7939 An Oral, Direct Factor Xa Inhibitor with Fondaparinux and Enoxaparin |
| |
- |
Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications |
| |
- |
Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases |
| |
- |
Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax |
| |
- |
Interaction of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor with Antiplatelet Agents: Monitoring and Therapeutic Applications |
| Cunningham M |
- |
Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP) |
| Cunto E |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| Cupanik V |
- |
Gynaecological Problems in Severe Congenital Factor VII Deficiency |
| Cupit LD |
- |
Platelets Express Steroidogenic 17bhydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype |
| Curmi PMG |
- |
A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice |
| Curnow J |
- |
Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients |
| Curtin P |
- |
Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China |
| Curtin J |
- |
Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients |
| Curtin R |
- |
Unusual Haplotypic Associations with Marked GPIIIa Allelic Expression Bias in the Platelets of PlA2 Heterozygotes |
| Curtis D |
- |
Effects of G-CSF/SCF on Cardiac Function and Cellular Repair Processes after Acute Myocardial Infarction |
| Curtiss LK |
- |
The Beige Mutation Is Atheroprotective in Apolipoprotein E-Deficient Mice |
| Curvers J |
- |
Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation |
| Curvers J |
- |
Platelet ADP Receptor Function Rapidly Deteriorates in Additive Solutions |
| Curvers J |
- |
Plasma Ecto-NTPDase Prevents Platelet P2X1 and P2Y12 Receptor Desensitization During Storage |
| |
- |
Platelet Derived Microparticles in Blood Bank Products Do Not Expose Functionally Active Tissue Factor But Are Highly Procoagulant |
| Cushman M |
- |
Dietary Vitamin B6 and Folate Intake is Inversely Related to Risk of Developing Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE) |
| Cutini C |
- |
Collagen-Induced Platelet Shape Change Does Not Require Positive Feedback Activators and Is Insensitive to cAMP Elevating Agents |
| Cutter J |
- |
Apoptotic Mechanisms Underlying High-Risk Plaque |
| Cuzon G |
- |
Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells |
| Cymbalista CM |
- |
CCAAT Enhancer Binding Proteins: Co-Regulators of Haemostasis and the Metabolic Syndrome? |
| Czerwiec E |
- |
Precursors of Novel Gla-Containing Conotoxins Contain a Carboxy-Terminal Recognition Site that Directs g-Carboxylation by g-Glutamyl Carboxylase |
| Czestochowska E |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| Czlonkowska A |
- |
Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke |
| Czuriga I |
- |
Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction |
| Czwalinna A |
- |
Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia |